Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1 diabetes

Diabetes

Volumn 65, Issue 5, 2016, Pages 1362-1369

  Leete, Pia ^a   Willcox, Abby ^a   Krogvold, Lars ^b,c   Dahl Jørgensen, Knut ^b,c   Foulis, Alan K ^d   Richardson, Sarah J ^a   Morgan, Noel G ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ALGORITHM; AUTOIMMUNE DISEASE; AUTOPSY; COMPARATIVE STUDY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFANT; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; UNITED KINGDOM; YOUNG ADULT;

CD20 ANTIGEN; INSULIN;

ADOLESCENT; ADULT; AGE OF ONSET; ALGORITHMS; ANTIGENS, CD20; AUTOIMMUNE DISEASES; AUTOPSY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INSULIN; MALE; PANCREAS; PANCREATITIS; UNITED KINGDOM; YOUNG ADULT;

EID: 84964661224     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1615     Document Type: Article

References (26)

1. Roep BO, Tree TI. Immune modulation in humans: implications for type 1 diabetes mellitus. Nat Rev Endocrinol 2014;10:229-242
2. Morgan NG, Leete P, Foulis AK, Richardson SJ. Islet inflammation in human type 1 diabetes mellitus. IUBMB Life 2014;66:723-734
3. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014;383:69-82
4. Campbell-Thompson ML, Atkinson MA, Butler AE, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia 2013;56:2541-2543
5. In't Veld P. Rodent versus human insulitis: why the huge disconnect? Curr Opin Endocrinol Diabetes Obes 2015;22:86-90
6. In't Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011;3:131-138
7. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009;155:173-181
8. Arif S, Leete P, Nguyen V, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 2014;63:3835-3845
9. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986;29:267-274
10. Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 2014;57:841-843
11. Campbell-Thompson M. Organ donor specimens: what can they tell us about type 1 diabetes? Pediatr Diabetes 2015;16:320-330
12. Pugliese A, Vendrame F, Reijonen H, Atkinson MA, Campbell-Thompson M, Burke GW. New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation. Curr Diab Rep 2014;14:530
13. Atkinson MA. ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 2005;54:1253-1263
14. Gale EA. Can we change the course of beta-cell destruction in type 1 diabetes? N Engl J Med 2002;346:1740-1742
15. Battaglia M, Atkinson MA. The streetlight effect in type 1 diabetes. Diabetes 2015;64:1081-1090
16. Klöppel G, Löhr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985;4:110-125
17. Klinke DJ 2nd. Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PLoS One 2008;3:e1374
18. Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 1992;8:209-227
19. Lernmark A, Klöppel G, Stenger D, et al. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 1995;425:631-640
20. Atkinson MA, von Herrath M, Powers AC, Clare-Salzler M. Current concepts on the pathogenesis of type 1 diabetes-considerations for attempts to prevent and reverse the disease. Diabetes Care 2015;38:979-988
21. Rodriguez-Calvo T, Suwandi JS, Amirian N, et al. Heterogeneity and lobularity of pancreatic pathology in type 1 diabetes during the prediabetic phase. J Histochem Cytochem 2015;63:626-636
22. Richardson SJ, Morgan NG, Foulis AK. Pancreatic pathology in type 1 diabetes mellitus. Endocr Pathol 2014;25:80-92
23. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 2011;33:9-21
24. Krogvold L, Skog O, Sundström G, et al. Function of isolated pancreatic islets from patients at onset of type 1 diabetes; insulin secretion can be restored after some days in a non-diabetogenic environment in vitro. Results from the DiViD study. Diabetes 2015;64:2506-2512
25. Pescovitz MD, Greenbaum CJ, Bundy B, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes Care 2014;37:453-459
26. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009;361:2143-2152